Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMLR
4226
DELISTED
Semler Scientific
SMLR
| $180K | ﹤0.01% |
7,664
-3,626
| -32% | -$104K |
|
|
BCOV
4227
DELISTED
Brightcove, Inc.
BCOV
| $180K | ﹤0.01% |
83,465
-11,303
| -12% | -$25.3K |
|
4228
RCM Technologies
RCMT
$201M
| $180K | ﹤0.01% |
+8,888
| New | +$172K |
|
4229
Sky Harbour Group
SKYH
$369M
| $180K | ﹤0.01% |
16,315
+12,490
| +327% | +$133K |
|
4230
Precigen
PGEN
$2.24B
| $179K | ﹤0.01% |
189,353
+124,141
| +190% | +$157K |
|
4231
Cerence
CRNC
$385M
| $179K | ﹤0.01% |
56,870
+38,741
| +214% | +$114K |
|
4232
PUT
Mobileye
MBLY
$2B
| $178K | ﹤0.01% |
+13,000
| New | +$228K |
|
4233
Priority Technology Holdings
PRTH
$535M
| $178K | ﹤0.01% |
26,064
+18,741
| +256% | +$105K |
|
4234
Innovator US Equity Buffer ETF July
BJUL
$346M
| $178K | ﹤0.01% |
+4,072
| New | +$173K |
|
4235
Innovator Buffer Step-Up Strategy ETF
BSTP
$60.2M
| $177K | ﹤0.01% |
+5,404
| New | +$172K |
|
4236
Forafric Global
AFRI
$289M
| $176K | ﹤0.01% |
15,522
+5,641
| +57% | +$62.7K |
|
|
VTYX
4237
DELISTED
Ventyx Biosciences
VTYX
| $175K | ﹤0.01% |
80,295
+58,776
| +273% | +$135K |
|
4238
MediciNova
MNOV
$65.5M
| $174K | ﹤0.01% |
82,800
-400
| -0.5% | -$592 |
|
4239
Quantum-Si Incorporated
QSI
$155M
| $174K | ﹤0.01% |
196,826
+133,438
| +211% | +$130K |
|
4240
Sanara MedTech
SMTI
$311M
| $173K | ﹤0.01% |
5,731
+4,376
| +323% | +$136K |
|
4241
Paysign
PAYS
$501M
| $173K | ﹤0.01% |
47,090
+36,071
| +327% | +$164K |
|
4242
Tootsie Roll Industries
TR
$2.93B
| $172K | ﹤0.01% |
5,905
+4,100
| +227% | +$117K |
|
4243
Geospace Technologies
GEOS
$94.6M
| $172K | ﹤0.01% |
16,622
+12,227
| +278% | +$117K |
|
4244
CALL
Arm
ARM
$256B
| $172K | ﹤0.01% |
1,200
-138,600
| -99% | -$19.7M |
|
4245
The ONE Group
STKS
$56.2M
| $171K | ﹤0.01% |
46,508
+22,580
| +94% | +$90.8K |
|
4246
Century Casinos
CNTY
$34M
| $171K | ﹤0.01% |
66,852
-412
| -0.6% | -$1.01K |
|
4247
Core Molding Technologies
CMT
$202M
| $171K | ﹤0.01% |
9,942
+7,318
| +279% | +$128K |
|
4248
Taylor Devices
TAYD
$165M
| $171K | ﹤0.01% |
3,426
+2,621
| +326% | +$135K |
|
4249
Ispire Technology
ISPR
$83.2M
| $170K | ﹤0.01% |
27,461
+20,782
| +311% | +$150K |
|
|
LSB
4250
DELISTED
LakeShore Biopharma
LSB
| $169K | ﹤0.01% |
24,758
| – | – |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.